The University of Massachusetts Human Stem Cell Bank and Registry and the United Kingdom Stem Cell Bank have reportedly agreed to collaborate on best practices for stem cell banking, including delivery of stem cell lines for clinical use, and may explore funding opportunities for joint research projects. Providing stem cell lines to researchers working on new therapeutic treatments for degenerative illnesses, such as Parkinson’s disease or diabetes, the banks plan to establish standards for stem cell line characterization, production and distribution, and will facilitate training events for stem cell researchers worldwide.

“By working closely together we have every reason to hope that we will be able to realize the full potential of stem cell research and bring breakthroughs to the clinic more quickly,” Rob Buckle of UK’s Neurosciences and Mental Health at the Medical Research Council told a news source. See BioNews, March 21, 2011.